Breakfast - 07:30-08:30

Symposium 4: Rethinking survivorship & supporting patients living with disease - 08:30-10:30

08:30 10:30

Rethinking survivorship & supporting patients living with disease Imperial 4PDQ pragmatic trial in ovarian cancer - Laura Hopkins Frail to fit: Exploring the role of pre-habilitative exercise in advanced ovarian cancer - Melanie Keats / Tom Christensen Patients at the forefront of research - Alicia Tone, Jim Petrik, and OCC Patient Partner Co-leads Donna Pepin and Shannon Kadar

> SYMP-4

Health break - 10:30-10:45

Symposium 5: Looking forward to new and exciting treatments - 10:45-12:40

10:45 12:40

Looking forward to new and exciting treatments Imperial Uncovering immune evasion mechanisms in ovarian cancer - Livnat Jerby Team translational science: OV21/PETROC - Helen MacKay Tracking therapy-induced senescence in ovarian clear cell carcinoma using p21 based reporter - Erwan Goy “Phyt”-ing back: nanophytoglycogen-potentiated long dsRNA as a novel ovarian cancer immunotherapeutic - Sarah Poynter Patient partner - Starla Fiddler

> SYMP-5

Closing Remarks & Best Abstract Awards & Next CCOCR - 12:30-13:00